Beefing up the Bio Weapons Convention

After a controversial suspension in 2001, work on the Biological Weapons Convention resumes in Geneva

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Efforts to strengthen implementation of the international treaty banning biological weapons have restarted after they collapsed in bitter disagreement in 2001. A meeting of experts in Geneva, running from August 18 to 29, is being hosted by the United Nations to find a new way forward for the troubled process.

"It's a long, sad story," Richard Lennane, political affairs officer at the UN Department of Disarmament Affairs in Geneva, told The Scientist. The Biological Weapons Convention (BWC) came into force in 1975 and commits the 150 states that are party to it to prohibit the development, production, and stockpiling of biological and toxin weapons. But there is no enforcement or verification machinery within the treaty. A long process of negotiation to add these missing elements began in the 1990s.

This resulted in a new protocol, to be agreed in time for the Fifth Review Conference of the convention in November ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrew Scott

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development